IAS 2017: A new $90-$90-$90 — that means affordable treatments for leading disease killers

Categories: IAS 2017PARIS – The math is not complicated: Take the cost of a drug’s active ingredient, add the “conversion” cost — that is the cost of turning that drug into a tablet — add costs for taxes, packaging, and tack on a 10 percent profit. The sum of that equation, Dr. Dzintars Gotham said here Tuesday, can […](Read more…)

The rest is here:
IAS 2017: A new $90-$90-$90 — that means affordable treatments for leading disease killers